Development of Rapid Donor Screening (RDS) Technology

The Government intends to develop Rapid Donor Screening (RDS) technology that is U.S. Food and Drug Administration (FDA) cleared with a donor screening indication. The Department of Defense (DoD) is seeking multiplexed assays for HIV-1 and -2, Hepatitis B and C, blood type and Rh factor, that use a whole blood sample and provides results in 20 minutes or less. The RDS shall ultimately support screening blood from the donors in conflict zones. The DoD requires technology that is rugged, lightweight, compact, and that operates with no requirement for connectivity to a cloud domain. Please review the Request for Prototype Proposal (RPP) and attachments for further details.